By Phil Boeyen, ShareChat Business News Editor
Wednesday 23rd May 2001 |
Text too small? |
Tower says to the end of March its profit rose 1% to $38.9 million compared with last year, reflecting a 25% increase in operating margins.
However sales for the period fell to $621.8 million from $896.2 million previously, and its operating surplus before unusual items and tax fell from $75.7 million last year to $49 million.
MD, James Boonzaier says has described the interim profit as "very satisfactory given the difficult market conditions."
He says the period was one of consolidation and change for the company, with the integration of three acquisitions - Bridges Financial Services and IOOF Trustees in Australia and AXA Health in New Zealand. Seven of the group's eight operating companies also underwent restructuring.
"The result is in line with expectations and Tower is now in a good position to achieve growth in the coming months, particularly if the investment climate is a little kinder," says Mr Boonzaier.
"Cost savings to be gained from the integrated operations are projected to be $7-$8 million per annum, and the integration of Bridges, together with the establishment of Goldridge, provide a strong financial planning backbone for growth."
Excluding foreign exchange effects Tower had asset growth of $600 million over last year, with total assets under management of $21.2 billion at the end of March.
Mr Boonzaier says the company has maintained its position as the country's top retail funds manager while continuing to build its position in the Australian wealth management sector.
Tower plans to pay an interim dividend of 14 cents per share, the same as last year.
No comments yet
Tower to return 'initial' $70M of capital from sale of life business
Tower shares fall to 2-month low as licensing requirements may weigh on capital returns
Tower's licensing talks with RBNZ may push up minimum solvency requirements
Tower names Hancock as new chief executive, replacing Flannagan
Tower posts first-half profit as asset sales reap gains of $51.4 mln
Fidelity Life acquires most of Tower's life insurance business
Flannagan to leave Tower after strategic review, asset sales
Tower FY profit jumps 67%, to return $120M to shareholders; shares jump
Tower sells medical insurance unit to nib for $102M
Stiassny joins Tower board as questions linger over strategy